Appointment booking for Dr. Clark Mcclurkin, MD is currently not available.Dr. Clark Mcclurkin, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Clark Mcclurkin, MD (he/him) is a Nephrologist in Evergreen Park, IL with over 18 years of experience. What is your opinion of Dr. Clark Mcclurkin, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Clark Mcclurkin, MD has received over $1,821 which includes payments from the following companies:
$344.75 from Keryx Biopharmaceuticals, Inc.
$275.04 from Relypsa, Inc.
$191.58 from Fresenius USA Marketing, Inc.
$164.19 from Amgen Inc.
$152.89 from OPKO Pharmaceuticals, LLC
$110.79 from Otsuka America Pharmaceutical, Inc.
$109.70 from sanofi-aventis U.S. LLC
$104.73 from AbbVie, Inc.
$99.68 from Baxter Healthcare
$82.15 from CryoLife, Inc.
$46.59 from Maquet Cardiovascular U.S. Sales, L.L.C.
$45.07 from AKEBIA THERAPEUTICS INC
$20.57 from AMAG Pharmaceuticals, Inc.
$19.27 from AstraZeneca Pharmaceuticals LP
$18.26 from Mallinckrodt LLC
$15.98 from GENZYME CORPORATION
$10.66 from Merck Sharp & Dohme Corporation
$9.93 from Boston Scientific Corporation
Payments received by Dr. Clark Mcclurkin, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!